塞力醫療(603716.SH):首批運往土耳其出口訂單尚未開始運送
格隆匯3月14日丨塞力醫療(603716.SH)發佈股票交易異常波動公吿,經公司自查,並向控股股東賽海科技及實際控制人温偉先生髮函核實,賽海科技擬通過協議轉讓方式引進戰略投資者、改善公司治理結構,相關事項實施與否仍存在較大不確定性。控股股東及實際控制人不存在應披露而未披露的重大信息。
公司自主研發的新型冠狀病毒抗原檢測試劑盒已經取得歐盟CE認證,可在歐盟市場銷售,公司已經申請但尚未取得中國國家藥品監督管理局頒發的《醫療器械註冊證》,尚無法在國內市場進行銷售。公司於2022年1月21日披露了《關於公司全資子公司簽訂日常經營重大合同的公吿》(公吿編號:2022-006),由於近期烏克蘭戰爭等國際形勢的變化,運輸成本大幅上漲,艙位緊張,因此公司首批運往土耳其出口訂單尚未開始運送。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.